Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

A Study to Evaluate the Safety of Nivolumab and Ipilimumab in Subjects With Previously Untreated Advanced or Metastatic Renal Cell Cancer

ClinicalTrials.gov ID: NCT02982954

Public ClinicalTrials.gov record NCT02982954. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 10:05 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase 3b/4 Safety Trial of Nivolumab Combined With Ipilimumab in Subjects With Previously Untreated, Advanced or Metastatic RCC (CheckMate 920: CHECKpoint Pathway and nivoluMAb Clinical Trial Evaluation 920)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To investigate the safety of Nivolumab in combination with Ipilimumab in subjects with previously untreated advanced or metastatic Renal Cell Cancer.

Study identification

NCT ID
NCT02982954
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Bristol-Myers Squibb
Industry
Enrollment
211 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 16, 2017 (Actual)
Primary completion
May 11, 2020 (Actual)
Completion
Oct 6, 2021 (Actual)
Last update posted
Nov 1, 2022

2017 – 2021

United States locations

U.S. sites
61
U.S. states
28
U.S. cities
57
Facility City State ZIP Site status
Northwest Alabama Cancer Center, Pc Muscle Shoals Alabama 35661 —
Alaska Urological Institute dba Alaska Clinical Research Center Anchorage Alaska 99503 —
Ironwood Cancer And Research Centers, Pc Chandler Arizona 85224 —
Local Institution - 0028 Fayetteville Arkansas 72703 —
eCare Encinitas California 92024 —
Pacific Shores Medical Group Long Beach California 90813 —
Los Angeles Cancer Network Los Angeles California 90017 —
UCLA Hematology Oncology Los Angeles California 90095 —
Torrance Health Association Redondo Beach California 90277 —
Kaiser Permanente Medical Group - Southern California Riverside California 92505 —
Sharp Memorial Hospital San Diego California 92123 —
Coastal Integrative Cancer Care San Luis Obispo California 93401 —
Central Coast Med Oncology Santa Maria California 93454 —
Florida Cancer Specialists S. Fort Myers Florida 33901 —
University Of Miami/Sylvester Cancer Center Miami Florida 33136 —
UF Health Cancer Center at Orlando Health Orlando Florida 32806 —
Florida Cancer Specialists St. Petersburg Florida 33705 —
Emory University - Winship Cancer Institute Atlanta Georgia 30322 —
Illinois Cancer Specialists Niles Illinois 60714 —
Local Institution - 0012 Fort Wayne Indiana 46845 —
Cancer Center Of Kansas Wichita Kansas 67214 —
Norton Cancer Institute Louisville Kentucky 40202 —
Southdale Cancer Clinic Burnsville Minnesota 55337 —
Local Institution - 0009 Coon Rapids Minnesota 55433 —
Park Nicollet Clinic Cancer Center Minneapolis Minnesota 55416 —
Hattiesburg Clinic Hattiesburg Mississippi 39401 —
Jackson Oncology Associates, Pllc Jackson Mississippi 39202 —
HCA Midwest Division Kansas City Missouri 64132 —
Comprehensive Cancer Centers of Nevada Las Vegas Nevada 89148 —
Local Institution - 0023 Hackensack New Jersey 07601 —
University Of New Mexico Albuquerque New Mexico 87106 —
Maimonides Medical Center Brooklyn New York 11220 —
St. Francis Cancer Treatment Center Grand Island New York 68803 —
Broome Oncology Johnson City New York 13790 —
Local Institution - 0052 New York New York 10016 —
Weill Cornell Medical College New York New York 10021 —
SUNY Upstate Medical University Syracuse New York 13210 —
Montefiore Medical Center The Bronx New York 10461 —
Duke University Medical Center Durham North Carolina 27710 —
Southeastern Medical Oncology Center Goldsboro North Carolina 27534 —
Oklahoma Cancer Specialists and Research Institute, LLC-Clinical Research Tulsa Oklahoma 74146 —
Local Institution - 0071 Pittsburgh Pennsylvania 15240 —
Charleston Hematology Oncology Associates, Pa Charleston South Carolina 29414 —
Hollings Cancer Center Charleston South Carolina 29425 —
Avera Cancer Institute Sioux Falls South Dakota 57105 —
Tennessee Oncology, PLLC - SCRI - PPDS Chattanooga Tennessee 37404 —
Local Institution - 0002 Nashville Tennessee 37203-1624 —
Vanderbilt University Medical Center Nashville Tennessee 37232-6307 —
Texas Oncology Austin Texas 78731 —
Texas Oncology Dallas Texas 75246 —
Texas Oncology-Fort Worth 12th Ave Fort Worth Texas 76104 —
Texas Oncology-Midland Allison Cancer Center Midland Texas 79701 —
Texas Oncology San Antonio Texas 78217 —
University of Virginia Health System Charlottesville Virginia 22936 —
Local Institution - 0042 Fairfax Virginia 22031 —
Bon Secours St Francis Hospital Midlothian Virginia 23114 —
Virginia Cancer Institute Richmond Virginia 23226 —
University of Washington - Seattle Cancer Care Alliance Seattle Washington 98109 —
Medical Oncology Associates Spokane Washington 99208 —
Yakima Valley Memorial Hospital/North Star Lodge Yakima Washington 98902 —
University of Wisconsin Clinical Science Center Madison Wisconsin 53705 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02982954, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 1, 2022 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02982954 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →